NasdaqCM - Nasdaq Real Time Price USD

Moleculin Biotech, Inc. (MBRX)

4.5400 0.0000 (0.00%)
At close: 3:53 PM EDT
4.6500 +0.11 (+2.42%)
After hours: 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
29,631.0000
29,631.0000
30,640.0000
22,968.0000
19,742.0000
Operating Income
-29,631.0000
-29,631.0000
-30,640.0000
-22,968.0000
-19,742.0000
Net Non Operating Interest Income Expense
1,368.0000
1,368.0000
240.0000
306.0000
13.0000
Other Income Expense
-1,506.0000
-1,506.0000
1,375.0000
6,768.0000
2,374.0000
Pretax Income
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Net Income Common Stockholders
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Diluted NI Available to Com Stockholders
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Basic EPS
-15.15
--
-15.30
-8.85
-26.40
Diluted EPS
-15.15
--
-15.30
-8.85
-26.40
Basic Average Shares
1,965.7810
--
1,897.4720
1,791.7280
656.3790
Diluted Average Shares
1,965.7810
--
1,897.4720
1,791.7280
656.3790
Total Operating Income as Reported
-29,631.0000
-29,631.0000
-30,640.0000
-22,968.0000
-19,742.0000
Total Expenses
29,631.0000
29,631.0000
30,640.0000
22,968.0000
19,742.0000
Net Income from Continuing & Discontinued Operation
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Normalized Income
-28,725.0000
-28,725.0000
-30,360.0000
-22,622.0000
-19,701.0000
Interest Income
1,368.0000
1,368.0000
240.0000
306.0000
13.0000
Net Interest Income
1,368.0000
1,368.0000
240.0000
306.0000
13.0000
EBIT
-29,631.0000
-29,631.0000
-30,640.0000
-22,968.0000
-19,742.0000
EBITDA
-29,504.0000
-29,504.0000
-30,510.0000
-22,804.0000
-19,542.0000
Reconciled Depreciation
127.0000
127.0000
130.0000
164.0000
200.0000
Net Income from Continuing Operation Net Minority Interest
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Total Unusual Items Excluding Goodwill
-1,044.0000
-1,044.0000
1,335.0000
6,728.0000
2,346.0000
Total Unusual Items
-1,044.0000
-1,044.0000
1,335.0000
6,728.0000
2,346.0000
Normalized EBITDA
-28,460.0000
-28,460.0000
-31,845.0000
-29,532.0000
-21,888.0000
12/31/2020 - 6/2/2016
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

GLMD Galmed Pharmaceuticals Ltd.
0.3728
-1.17%
 
VRPX Virpax Pharmaceuticals, Inc.
3.6801
-5.88%
 
CNSP CNS Pharmaceuticals, Inc.
0.2020
-1.46%
 
PRTG Portage Biotech Inc.
0.2710
+11.07%
 
RNAC Cartesian Therapeutics, Inc.
17.91
+3.65%
 
TRVN Trevena, Inc.
0.3520
-3.83%
 
ALRN Aileron Therapeutics, Inc.
4.7500
-5.00%
 
GNPX Genprex, Inc.
2.1350
-3.39%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5860
-6.54%
 
APVO Aptevo Therapeutics Inc.
0.7274
-5.53%